Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FBIO
#4017
Fortress Biotech, Inc. - Common Stock
2.1
1
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.40%
Monthly Change
-15.60%
6 month change
-13.17%
Year Change
-21.85%
Previous Close
2.1
4
Open
2.1
2
Low
2.1
0
High
2.1
3
Markets
US Stock Market
Healthcare
Biotechnology
FBIO
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Documents
2012
Quarterly report, Q1 FY2012
2012.05.15
Fortress Biotech, Inc. quarterly report, Q1 FY2012
10-Q
2011
Annual report, FY2011
2012.03.29
Fortress Biotech, Inc. annual report, FY2011
10-K
Quarterly report, Q3 FY2011
2011.11.14
Fortress Biotech, Inc. quarterly report, Q3 FY2011
10-Q
1
2
3
4
5
6
7
8
9
10
News
Fortress Biotech, Inc. (FBIO) Q2 2026 Earnings Call Transcript
Fortress Biotech: Cash Above Market Cap And Royalty Upside Make This A Speculative Buy
Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends? (FBIO)
Avenue Therapeutics licenses ATX-04 for Pompe disease treatment
Fortress Biotech Stock: The PRV Catalyst That Could Reprice This Microcap (NASDAQ:FBIO)
Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes
Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums
Centene Expands Palliative Care Access in Ohio Through Tuesday Health
FDA approves first treatment for Menkes disease in children
FDA sets new PDUFA date for Fortress Biotech’s Menkes disease therapy
Fortress Biotech (FBIO) Surpasses Q3 Earnings Estimates
Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript